Interesting appointment. Certainly reads well and that sort of experience on board clearly indicates they are moving forward with their plans. Very encouraging.
Even more encouraging was the quote by Mr Curnock Cook: “I was particularly attracted to the opportunity to develop Phylogica’s strategy, because it is not often that one has the opportunity to help grow a company, which controls global access to a new source of proprietary therapeutics. This is an important period of transition for the company since it has recently entered the commercialisation phase, as it continues to validate its technology, both scientifically and through accumulating Pharma alliances. I believe that if Phylogica continues on its current trajectory, the Company will prove an attractive acquisition target for the pharmaceutical industry.”
Things like:
...controls global access to a new source of proprietory therapeutics...
... recently entered the commercialisation phase.... (Note: Is there something we haven't been told here?)
...the company will prove an attractive acquisition target...
all music to the ears of an investor...!!:-)
Interesting appointment. Certainly reads well and that sort of...
Add to My Watchlist
What is My Watchlist?
